News

InvestorsHub on MSN35m

Gilead shares drop after CVS delays coverage for HIV prevention shot

Gilead Sciences (NASDAQ:GILD) saw its stock decline 2.7% in pre-market trading Thursday following news that CVS Health ...

Exclusive-CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told ...